Oxygenta Pharmaceutical Statistics

Total Valuation

BOM:524636 has a market cap or net worth of INR 3.91 billion. The enterprise value is 4.53 billion.

Market Cap	3.91B
Enterprise Value	4.53B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BOM:524636 has 36.98 million shares outstanding. The number of shares has increased by 12.39% in one year.

Current Share Class	36.98M
Shares Outstanding	36.98M
Shares Change (YoY)	+12.39%
Shares Change (QoQ)	-2.27%
Owned by Insiders (%)	37.88%
Owned by Institutions (%)	n/a
Float	2.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.57
PB Ratio	-15.23
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	150.05
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-43.95
EV / Sales	4.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-51.50

Financial Position

The company has a current ratio of 0.36

Current Ratio	0.36
Quick Ratio	0.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-7.08
Interest Coverage	-3.24

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-10.04%
Return on Invested Capital (ROIC)	-19.89%
Return on Capital Employed (ROCE)	385.34%
Revenue Per Employee	6.79M
Profits Per Employee	-639,646
Employee Count	161
Asset Turnover	1.50
Inventory Turnover	6.29

Taxes

Income Tax	-40.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +237.43% in the last 52 weeks. The beta is 0.50, so BOM:524636's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+237.43%
50-Day Moving Average	107.90
200-Day Moving Average	89.56
Relative Strength Index (RSI)	39.08
Average Volume (20 Days)	3,880

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524636 had revenue of INR 1.09 billion and -102.98 million in losses. Loss per share was -2.86.

Revenue	1.09B
Gross Profit	16.68M
Operating Income	-117.26M
Pretax Income	-143.51M
Net Income	-102.98M
EBITDA	-81.12M
EBIT	-117.26M
Loss Per Share	-2.86

Full Income Statement

Balance Sheet

The company has 1.22 million in cash and 622.32 million in debt, giving a net cash position of -621.11 million or -16.79 per share.

Cash & Cash Equivalents	1.22M
Total Debt	622.32M
Net Cash	-621.11M
Net Cash Per Share	-16.79
Equity (Book Value)	-256.41M
Book Value Per Share	-7.15
Working Capital	-549.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 26.03 million and capital expenditures -113.92 million, giving a free cash flow of -87.89 million.

Operating Cash Flow	26.03M
Capital Expenditures	-113.92M
Free Cash Flow	-87.89M
FCF Per Share	-2.38

Full Cash Flow Statement

Margins

Gross margin is 1.53%, with operating and profit margins of -10.73% and -9.42%.

Gross Margin	1.53%
Operating Margin	-10.73%
Pretax Margin	-13.13%
Profit Margin	-9.42%
EBITDA Margin	-7.42%
EBIT Margin	-10.73%
FCF Margin	n/a

Dividends & Yields

BOM:524636 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.39%
Shareholder Yield	n/a
Earnings Yield	-2.64%
FCF Yield	-2.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5